RIA is widely used in oncology for the detection and monitoring of cancer biomarkers. These biomarkers can include hormones, enzymes, and proteins that are indicative of cancerous activity. Examples include measuring levels of prostate-specific antigen (PSA) for prostate cancer, CA-125 for ovarian cancer, and alpha-fetoprotein (AFP) for liver cancer.
